Epigenetically upregulating TROP2 enhances therapeutic efficacy of TROP2 ADC sacitizumab govitecan

被引:0
|
作者
Zhao, Ming [1 ]
DiPeri, Timothy P. [1 ]
Raso, Gabriela [1 ]
Rizvi, Yasmeen Q. [1 ]
Zheng, Xiaofeng [1 ]
Evans, Kurt [1 ]
Akcakanat, Argun [1 ]
Yang, Fei [1 ]
Tripathy, Debu [1 ]
Dumbrava, Ecaterina Ileana [1 ]
Damodaran, Senthil [1 ]
Meric-Bernstam, Funda [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1791
引用
收藏
页数:2
相关论文
共 50 条
  • [21] TROP2: a potential marker in diagnosis of thyroid neoplasms
    Turan, Zubeyir
    Erkilic, Suna
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (01) : 99 - 103
  • [22] TROP2 Expression in Sebaceous and Sweat Gland Carcinoma
    Ito, Takamichi
    Hashimoto, Hiroki
    Tanaka, Yuka
    Tanegashima, Keiko
    Murata, Maho
    Ichiki, Toshio
    Iwasaki, Takeshi
    Oda, Yoshinao
    Kaku-Ito, Yumiko
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [23] TROP2 modulates the progression in papillary thyroid carcinoma
    Sun, Huali
    Chen, Qi
    Liu, Weiping
    Liu, Yanmei
    Ruan, Sihan
    Zhu, Chumeng
    Ruan, Yanyun
    Ying, Shenpeng
    Lin, Peipei
    JOURNAL OF CANCER, 2021, 12 (22): : 6883 - 6893
  • [24] Prognostic value of TROP2 in human nasopharyngeal carcinoma
    Guan, Guo-Fang
    Zhang, De-Jun
    Wen, Lian-Ji
    Yu, Duo-Jiao
    Zhao, Yan
    Zhu, Lin
    Guo, Ying-Yuan
    Zheng, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 10995 - 11004
  • [25] Targeting Trop2 for treatment of prostate and breast cancer
    Stoyanova, Tanya
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [26] TROP2: a potential marker in diagnosis of thyroid neoplasms
    Zübeyir Turan
    Suna Erkılıç
    Irish Journal of Medical Science (1971 -), 2023, 192 : 99 - 103
  • [27] Clinical significance of TROP2 expression in colorectal cancer
    Ohmachi, Takahiro
    Tanaka, Fumiaki
    Mimori, Koshi
    Inoue, Hiroshi
    Yanaga, Katsuhiko
    Mori, Masaki
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3057 - 3063
  • [28] TROP2 expression as prognostic marker for gastric carcinoma
    Muehlmann, G.
    Spizzo, G.
    Gostner, J.
    Zitt, M.
    Maier, H.
    Moser, P.
    Gastl, G.
    Zitt, M.
    Mueller, H. M.
    Margreiter, R.
    Oefner, D.
    Fong, D.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (02) : 152 - 158
  • [29] Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer
    Liu, Shiqin
    Hawley, Sarah
    Kunder, Christian
    Hsu, En-Chi
    Shen, Michelle
    Aslan, Merve
    Marques, Fernando J.
    Lee, Chung S.
    Bermudez, Abel
    Westphalen, Lennart
    Auman, Heidi
    Newcomb, Lisa F.
    Lin, Daniel W.
    Nelson, Peter S.
    Feng, Ziding
    Tretiakova, Maria S.
    True, Lawrence D.
    Vakar-Lopez, Funda
    Carroll, Peter R.
    Simko, Jeffry
    Gleave, Martin E.
    Troyer, Dean A.
    McKenney, Jesse K.
    Peehl, Donna
    Pitteri, Sharon J.
    Brooks, James D.
    Liss, Michael A.
    Stoyanova, Tanya
    CANCER RESEARCH, 2024, 84 (06)
  • [30] TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
    Lin, Jau-Chen
    Wu, Yi-Ying
    Wu, Jing-Yi
    Lin, Tzu-Chieh
    Wu, Chen-Tu
    Chang, Yih-Leong
    Jou, Yuh-Shan
    Hong, Tse-Ming
    Yang, Pan-Chyr
    EMBO MOLECULAR MEDICINE, 2012, 4 (06) : 472 - 485